covid
Buscar en
Anales de Pediatría Continuada
Toda la web
Inicio Anales de Pediatría Continuada Obesidad. Mediadores. Tratamientos futuros
Información de la revista
Vol. 1. Núm. 2.
Páginas 86-89 (enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 1. Núm. 2.
Páginas 86-89 (enero 2003)
Acceso a texto completo
Obesidad. Mediadores. Tratamientos futuros
Visitas
4045
Ángela Peñalva, Carlos Diéguez
Departamentos de Medicina y Fisiología. Facultad de Medicina. Universidad de Santiago de Compostela. Santiago de Compostela. España.
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
P.J. Havel.
Peripheral signals conveying metabolic information to brain: short-term and long-term regulation of food intake and energy homeostasis.
Exp Biol Med, 226 (2001), pp. 963-977
[2.]
M.W. Schwartz, S.C. Woods, R.L. Seeley, G.S. Barsh, D.G. Baskin, R.L. Leíbel.
Is the energy homeostasis system inherently biased toward weight gain?.
Diabetes, 52 (2003), pp. 232-238
[3.]
J.P. Wilding.
Neuropeptides and appetite control.
Diabet Med, 19 (2002), pp. 619-627
[4.]
Obesity-what is to be done?.
[special section].
Science, 299 (2003), pp. 845-860
[5.]
Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, J.M. Friedman.
Positional cloning of the mouse obese gene and its human homologue.
Nature, 372 (1994), pp. 425-432
[6.]
S. Collins, C.M. Khun, A.E. Petro, A.G. Swick, B.A. Chrunyk, R.S. Surwit.
Role of leptin in fat regulation.
Nature, 380 (1996), pp. 677-680
[7.]
I.S. Farooqi, S.A. Jebb, G. Langmack, E. Lawrence, C.H. Cheetham, A.H. Prentice, et al.
Effects of recombinant leptin therapy in a child with congenital leptin deficiency.
N England J Med, 341 (1999), pp. 879-884
[8.]
S.B. Heymsfield, A.S. Greenberg, K. Fujioka, R.M. Dixon, R. Kushner, T. Hunt, et al.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
J Am Med Assoc, 282 (1999), pp. 1568-1575
[9.]
C.J. Hukshorn, W.H. Saris, M.S. Westerterp-plantenga, A.R. Farid, F.J. Smith, L.A. Campfield.
Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men.
J Clin Endocrinol Metab, 85 (2000), pp. 4003-4009
[10.]
N.L. Keim, J.S. Stern, P.J. Havel.
Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women.
Am J Clin Nutr, 68 (1998), pp. 794-801
[11.]
J.F. Caro, J.W. Kolaczynski, M.R. Nyce, J.P. Ohannesian, I. Opentanova, W.H. Goldman, et al.
Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance.
Lancet, 348 (1996), pp. 159-161
[12.]
A. Hinney, A. Schmidt, K. Nottebom, O. Heibult, I. Becker, A. Ziegler, et al.
Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans.
J Clin Endocrinol Metab, 84 (1999), pp. 1483-1486
[13.]
V. Di Marzo, S.K. Goparaju, L. Wang, J. Liu, S. Batkai, Z. Jarai, et al.
Leptin-regulated endocannabinoids are involved in maintaining food intake.
Nature, 410 (2001), pp. 822-825
[14.]
M. Kojima, R. Haruno, M. Nakazato, Y. Date, N. Murakami, R. Hanada, et al.
Ghrelin is a growth hormone releasing-acylated peptide from stomach.
Nature, 402 (1999), pp. 656-660
[15.]
M. Nakazato, N. Murakami, Y. Date, M. Kojima, H. Matsuo, K. Kangawa, et al.
A role for ghrelin in the central regulation of feeding.
Nature, 409 (2001), pp. 194-198
[16.]
D.E. Cummings, J.Q. Purnell, R.S. Frayo, K. Schmidova, B.E. Wisse, D.S. Weigle.
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.
Diabetes, 50 (2001), pp. 1714-1719
[17.]
A. DelParigi, M. Tschop, M.L. Heiman, A.D. Salbe, B. Vozarova, S.M. Sell, et al.
High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader- Willi syndrome.
J Clin Endocrinol Metab, 87 (2002), pp. 5461-5464
[18.]
D.E. Cummings, K. Clement, J.Q. Purnell, C. Vaisse, K.E. Foster, R.S. Frayo, et al.
Elevated plasma ghrelin levels in Prader-Willi syndrome.
Nat Med, 87 (2002), pp. 643-644
[19.]
D.E. Cummings, D.S. Weigle, R.S. Frayo, P.A. Breen, M.K. Ma, E.P. Dellinger, et al.
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.
N Engl J Med, 346 (2002), pp. 1623-1630
[20.]
R.L. Batterham, M.A. Cowley, C.J. Small, H. Herzog, M.A. Cohen, C.L. Dakin, et al.
Gut hormone PYY (3-36) physiologically inhibits food intake.
Nature, 418 (2002), pp. 650-654
[21.]
L.P. Kozak, M.E. Harper.
Mitochondrial uncoupling proteins in energy expenditure.
Annu Rev Nutr, 20 (2000), pp. 339-363
[22.]
J. Martinez-botas, J.B. Anderson, D. Tessier, A. Lapillonne, B.H. Chang, M.J. Quast, et al.
Absence of perilipin results in leanness and reverses obesity in Lepr (db/db) mice.
Nat Genetic, 26 (2000), pp. 474-479
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos